Gateway for Cancer Research

• NCT07283848

  Collaborator, Phase 2, Withdrawn, 0 people, 16 Dec 2025

• NCT07021989

  Collaborator, Phase 2, Recruiting, 38 people, 15 Jun 2025

• NCT06268015

  Collaborator, Phase 2, Active, not recruiting, 16 people, 20 Feb 2024

• NCT06200155

  Collaborator, Phase 2, Recruiting, 48 people, 10 Jan 2024

• NCT05292664

  Collaborator, Phase 1, Recruiting, 30 people, 23 Mar 2022

• TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  Collaborator, Early phase 1, Active, not recruiting, 14 people, 22 Sept 2021

• Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  Collaborator, Phase 1, Active, not recruiting, 37 people, 24 May 2021

• NCT03194932

  Collaborator, Phase 1, Completed, 62 people, 21 Jun 2017

• NCT02553460

  Collaborator, Phase 1/2, Active, not recruiting, 50 people, 17 Sept 2015

• NCT02344355

  Collaborator, Phase 2, Active, not recruiting, 90 people, 22 Jan 2015

• NCT02296671

  Collaborator, Phase 2, Withdrawn, 0 people, 20 Nov 2014

• NCT01861002

  Collaborator, Phase 1, Completed, 15 people, 23 May 2013

• NCT01852890

  Collaborator, Phase 1, Completed, 16 people, 14 May 2013

• NCT01713400

  Collaborator, Phase 2, Completed, 54 people, 24 Oct 2012

• NCT00668707

  Collaborator, Phase 3, Completed, 709 people, 29 Apr 2008

Sources: clinicaltrials.gov